Home
About
Overview
Sharing Data
ORCID
Help
History (61)
Innovative health care disparities curriculum for incoming medical students.
Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trial.
Negative Patient Descriptors: Documenting Racial Bias In The Electronic Health Record.
DNA Breaks
New entities, issues, and controversies in the classification of malignant lymphoma.
See All 61 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
New entities, issues, and controversies in the classification of malignant lymphoma.
New entities, issues, and controversies in the classification of malignant lymphoma. Semin Oncol. 1998 Aug; 25(4):421-34.
View in:
PubMed
subject areas
Hodgkin Disease
Humans
Lymphoma
Lymphoma, Non-Hodgkin
authors with profiles
James W. Vardiman